(Reuters) - Indian stocks rose on Monday after a truce in trade relations between the United States and China, while shares in Hindustan Unilever jumped after its deal involving GlaxoSmithKline's Horlicks nutrition business.
The broader NSE Nifty closed 0.06 percent higher at 10,883.75, while the benchmark Sensex index ended 0.13 higher at 36,241. Both indexes marked their sixth successive session of gains.
Hindustan Unilever jumped 4.1 percent to its best ever closing level after a deal announced by its Anglo-Dutch parent Unilever to buy GlaxoSmithKline's Indian Horlicks business for $3.8 billion.
Meanwhile, shares in Sun Pharmaceutical Industries Ltd, India's top drug manufacturer by market value, slid 7.6 percent after a report of a regulatory probe against the company.
(Reporting by Chris Thomas in Bengaluru; Editing by Sai Sachin Ravikumar)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app